Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
The Journal of Infectious Diseases
|
December 18, 2012
Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae
Elizabeth B Hirsch, Beining Guo, Kai-Tai Chang, et al.
Therapeutic Advances in Infectious Disease
|
June 19, 2023
Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
Kaylyn N Billmeyer, Jennifer K Ross, Elizabeth B Hirsch, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
November 23, 2018
Volatile metabolic diversity of <i>Klebsiella pneumoniae</i> in nutrient-replete conditions
Christiaan A Rees, Katherine V Nordick, Flavio A Franchina, et al.
Microbiology Spectrum
|
June 28, 2024
Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for <i>Klebsiella pneumoniae</i>
Morgan L Bixby, Ellora C Daley, Lindsey B Collins, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria
Elizabeth B Hirsch, Kimberly R Ledesma, Kai-Tai Chang, et al.
Antimicrobial Agents and Chemotherapy
|
February 18, 2016
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics
Elizabeth B Hirsch, Paola C Zucchi, Alice Chen, et al.
Journal of Bacteriology
|
April 13, 2022
The Atypical Antipsychotic Quetiapine Promotes Multiple Antibiotic Resistance in Escherichia coli
Yasuhiro Kyono, Lori Ellezian, YueYue Hu, et al.
The Journal of Antimicrobial Chemotherapy
|
March 6, 2018
Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model
Hajira Bilal, Anton Y Peleg, Michelle P McIntosh, et al.
Jac-Antimicrobial Resistance
|
February 21, 2025
Heteroresistance associated with the production of fosfomycin-resistant inner colonies during disk diffusion testing among a geographically diverse collection of <i>Klebsiella pneumoniae</i> clinical isolates
Morgan L Bixby, Lindsey B Collins, Ellora C Daley, et al.
The Journal of Antimicrobial Chemotherapy
|
April 28, 2016
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance
Clare C Walsh, Cornelia B Landersdorfer, Michelle P McIntosh, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
The Journal of Infectious Diseases
|
December 18, 2012
Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae
Elizabeth B Hirsch, Beining Guo, Kai-Tai Chang, et al.
Therapeutic Advances in Infectious Disease
|
June 19, 2023
Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
Kaylyn N Billmeyer, Jennifer K Ross, Elizabeth B Hirsch, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
November 23, 2018
Volatile metabolic diversity of <i>Klebsiella pneumoniae</i> in nutrient-replete conditions
Christiaan A Rees, Katherine V Nordick, Flavio A Franchina, et al.
Microbiology Spectrum
|
June 28, 2024
Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for <i>Klebsiella pneumoniae</i>
Morgan L Bixby, Ellora C Daley, Lindsey B Collins, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria
Elizabeth B Hirsch, Kimberly R Ledesma, Kai-Tai Chang, et al.
Antimicrobial Agents and Chemotherapy
|
February 18, 2016
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics
Elizabeth B Hirsch, Paola C Zucchi, Alice Chen, et al.
Journal of Bacteriology
|
April 13, 2022
The Atypical Antipsychotic Quetiapine Promotes Multiple Antibiotic Resistance in Escherichia coli
Yasuhiro Kyono, Lori Ellezian, YueYue Hu, et al.
The Journal of Antimicrobial Chemotherapy
|
March 6, 2018
Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model
Hajira Bilal, Anton Y Peleg, Michelle P McIntosh, et al.
Jac-Antimicrobial Resistance
|
February 21, 2025
Heteroresistance associated with the production of fosfomycin-resistant inner colonies during disk diffusion testing among a geographically diverse collection of <i>Klebsiella pneumoniae</i> clinical isolates
Morgan L Bixby, Lindsey B Collins, Ellora C Daley, et al.
The Journal of Antimicrobial Chemotherapy
|
April 28, 2016
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance
Clare C Walsh, Cornelia B Landersdorfer, Michelle P McIntosh, et al.
Page
of 8